ZC3H13 and cancer: We downloaded survival data for GC patients from the Asian Cancer Research Group (ACRG) and The Cancer Genome Atlas (TCGA) databases and found that patients with the overexpression of ZC3H13 had decreased overall survival (OS) (Fig. 1C) and relapse-free survival (RFS) (Fig. 1D).